AI Applications for Drug Discovery Development BioPharm America™: Innovation and Investing Boston CEO&BD Drug Delivery Partnerships
LIVE SESSIONS and ON-DEMAND SESSIONS Live sessions may only be seen at the time listed. On-demand sessions will be released at the time listed.
September 21
10:25am–10:30am LIVE Welcome and Introduction from the Conference Director
10:30am–10:50am ON DEMAND Keynote: What will AI actually solve in the next 5–10 years?
11:00am–11:40am ON DEMAND What does precision medicine actually mean and how can AI and ML impact it?
11:45am–12:05pm ON DEMAND Fireside Chat: Using AI to optimize drug selection and development
12:05pm–12:25pm ON DEMAND Conversational AI and chat bots
1:00pm–1:20pm ON DEMAND Optimization and experimental outcome validation
LIVE SESSIONS and ON-DEMAND SESSIONS
September 21 (continued)
1:20pm–1:40pm ON DEMAND AI for clinical trial design: Failing fast to succeed faster
September 23
10:25am–10:30am Welcome and Introduction from the Conference Director
10:30am–10:50am ON DEMAND What are the big questions AI can help answer and what's holding us back?
10:50am–11:10am ON DEMAND Portfolio management and business models
1:00pm–1:20pm ON DEMAND Building a data foundation for AI and ML applications
1:20pm–2:00pm ON DEMAND Responsible AI and machine learning for drug discovery and development
LIVE SESSIONS AND ON-DEMAND SESSIONS
September 24
10:30am–10:50am ON DEMAND AI and genomic approaches to diagnostics in the rare-disease space
10:50am–11:10am ON DEMAND AI in hospitals for operational excellence, clinical decision support and predicting treatment outcomes
11:30am–12:00pm ON DEMAND Privacy: Data and consent in the drug development lifecycle – Regulatory compliance and ethics frameworks in the application of AI and ML
ON-DEMAND SESSIONS INNOVATION AND INVESTING
BioPharm America™ Startup Pitch Competition
Many shots on goal: Evotec’s business model
The IndieBio accelerator model
The digital story: How Bayer is playing it
Pharma open innovation: Bayer’s case study
Challenging the norms of early stage investment
Early stage funding trends in Europe
View full agenda here
LIVE SESSIONS September 22 (Full day)
9:30am–9:35am LIVE Opening remarks
9:35am–10:05am LIVE The role of patient advocacy groups and disease foundations in our ecosystem
10:05am–10:35am LIVE Top considerations when engaging a potential strategic partnership
10:35am–11:00am LIVE Fireside chat: Maximizing value in an M&A
11:00am–11:15am LIVE Ginkgo Bioworks
11:15am–12:00pm LIVE Fireside chat: Pricing
12:00pm–12:45pm LIVE Lunch Break & Networking Lounge
LIVE SESSIONS September 22 (continued)
12:45pm–1:15pm LIVE Keynote Address
1:15pm–1:45pm LIVE Diversity and inclusion: Cultivating the next generation of biotech execs
1:45pm–2:15pm LIVE Fireside chat: The mentor/mentee relationship
2:15pm–2:45pm LIVE To go IPO or remain private?
2:45pm–3:15pm LIVE Building your biotech from the ground up
3:15pm–3:45pm LIVE New players in the healthcare space
3:45pm–4:15pm LIVE The convergence of AI and medicine
9:00am–9:30am ON DEMAND Master Class A, part 1: Alliance management - concepts and tools to make the best out of your partnerships
9:30am–10:15am ON DEMAND Master Class A, part 2: Alliance management - concepts and tools to make the best out of your partnerships
10:15am–11:00am ON DEMAND Master Class A, part 3: Alliance management - concepts and tools to make the best out of your partnerships
11:00am–11:30am ON DEMAND Master Class A, part 4: Alliance management - concepts and tools to make the best out of your partnerships
11:30am–12:00pm LIVE Master Class A, part 5: Q&A Discussion
12:00pm–2:15pm ON DEMAND Master Class B, parts 1 & 2: Negotiation for drug delivery
2:15pm–3:00pm LIVE Master Class B, part 3: Negotiation for drug delivery innovation
3:00pm–3:45pm LIVE Master Class B, part 4: Negotiation for drug delivery innovatio
September 22
10:40am–11:00am ON DEMAND USP 800 - How it will affect drug delivery and formulations
11:00am–11:20am ON DEMAND Regulatory and scientific justifications for CMC Changes - Case studies of modified release products
11:20am–11:40am ON DEMAND EU/MDR/IVDR combination product and companion product considerations
September 23 10:25am–10:30 am Welcome Address
10:30am–10:50am LIVE Innovations in drug delivery that are shaping the future of drug product science and manufacturing
10:55am–11:15am LIVE Innovate inside the box: Challenges and considerations when customizing a platform delivery device
1:00pm–1:20pm ON DEMAND Case study: Alleviating challenges of oral peptide delivery
1:00pm–1:20pm ON DEMAND Ionic liquids for drug delivery
1:20pm–1:40pm ON DEMAND Case Study: Creating a connected platform for pre-filled syringes while minimizing cost
1:20pm–1:40pm ON DEMAND Brain delivery of biologics – VIA cerebrospinal fluid
1:40pm–2:00pm ON DEMAND Update: Development of dual-chamber reconstitution systems and fill-finish capabilities
1:40pm–2:00pm ON DEMAND Challenges and opportunities to improving the subcutaneous delivery of biologics
2:00pm–2:30pm ON DEMAND Connectivity in drug delivery – strategies from the leaders of the pack
2:00pm–2:20pm ON DEMAND Learning and challenges: Release testing and simulations for long acting parenteral products
10:25am–10:30am Welcome Address – Drug Delivery Partnerships 1 & 2
10:30am–10:50am ON DEMAND Drawing the parallels of innovation from design firms to pharma - An IDEO perspective
10:55am–11:25am ON DEMAND De-risking partnerships – Best practices to working with start-ups, pharma, and novel technologies
11:40am–12:00pm ON DEMAND Pandemic prevention through gene therapy delivery
1:00pm–1:20pm ON DEMAND Technological advances to address oral delivery of challenging molecules
1:00pm–1:20pm ON DEMAND Linking the device to the patient
1:20pm–1:40pm ON DEMAND 3ml patchpump platform: Adaptations for simple and complex therapies
1:20pm–2:00pm ON DEMAND Patient inclusion during design: From human factors studies to patient boards